perflutren has been researched along with Polyps in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kitagawa, Y; Mori, R; Shimada, H; Tanaka, K; Yuzawa, M | 1 |
| Basia, A; Ratra, D | 1 |
| Jackson, TL; Liazos, E; McHugh, D; Papavasileiou, E; Steel, DH | 1 |
3 other study(ies) available for perflutren and Polyps
| Article | Year |
|---|---|
Intravitreal Tissue Plasminogen Activator, Ranibizumab, and Gas Injection for Submacular Hemorrhage in Polypoidal Choroidal Vasculopathy.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroidal Neovascularization; Combined Modality Therapy; Endotamponade; Female; Fibrinolytic Agents; Fluorescein Angiography; Fluorocarbons; Humans; Intravitreal Injections; Male; Middle Aged; Polyps; Prone Position; Prospective Studies; Ranibizumab; Retinal Hemorrhage; Tissue Plasminogen Activator; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2016 |
Intravitreous tissue plasminogen activator with pneumatic displacement in submacular hemorrhage.
Topics: Choroid Diseases; Coloring Agents; Female; Fibrinolytic Agents; Fluorescein Angiography; Fluorocarbons; Humans; Indocyanine Green; Intravitreal Injections; Middle Aged; Polyps; Retinal Hemorrhage; Supine Position; Tissue Plasminogen Activator | 2012 |
Intravitreal tissue plasminogen activator, perfluoropropane (C3F8), and ranibizumab or photodynamic therapy for submacular hemorrhage secondary to wet age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Choroid Diseases; Combined Modality Therapy; Endotamponade; Female; Fibrinolytic Agents; Fluorocarbons; Humans; Intravitreal Injections; Male; Middle Aged; Photochemotherapy; Polyps; Prone Position; Ranibizumab; Retinal Hemorrhage; Retrospective Studies; Tissue Plasminogen Activator; Tomography, Optical Coherence; Visual Acuity; Wet Macular Degeneration | 2013 |